EDOC:SW:SW-Global X Telemedicine & Digital Health ETF A CHF (CHF)

ETF | Others |

Last Closing

USD 6.296

Change

-0.35 (-5.31)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

-0.59 (-4.54%)

USD 1,244,681.59B
SPISI:SW UBS ETF (CH) - SPI® ESG (CHF)..

-0.59 (-3.95%)

USD 590,186.66B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

-0.98 (-5.01%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

-1.11 (-4.24%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

-106.00 (-1.13%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+113.00 (+1.90%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+36.40 (+1.96%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+17.50 (+0.71%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

-2.94 (-4.09%)

USD 131,872.43B

ETFs Containing EDOC:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.74% 9% A- 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.74% 9% A- 10% F
Trailing 12 Months  
Capital Gain -4.92% 15% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.92% 14% F 19% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -4.37% 5% F 8% B-
Dividend Return -4.37% 4% F 8% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.16% 27% F 35% F
Risk Adjusted Return -33.23% 7% C- 9% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.